13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q3 2020. See the latest, Q2 2026 →
Reported value
$27.68B
+20% on the quarter before
Positions
86
32 new · 18 sold out
Top 10
40.5%
of the value
Est. gain
+$1.38B
on stocks held all quarter
Est. return
+8.1%
on those stocks since Q2 2020
Positions as of Sep 30, 2020, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2020. Striped tiles are options.
Largest buys
Since Q2 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$956.2MAdded · 3.3% → 6.3%+4,546,346 shares
- TSMC~$498.3MNew · 0.0% → 1.8%+6,147,123 shares
- T-Mobile Us Inc~$488.4MAdded · 1.7% → 3.3%+4,270,569 shares
- MercadoLibre~$437.4MAdded · 0.3% → 1.9%+404,104 shares
- Avalonbay Cmntys Inc~$381.3MNew · 0.0% → 1.4%+2,553,481 shares
- AMD~$369.0MNew · 0.0% → 1.3%+4,500,835 shares
- Raytheon Technologies Corp~$353.7MNew · 0.0% → 1.3%+6,147,033 shares
- Fidelity Natl Information Sv~$319.8MAdded · 3.9% → 4.7%+2,172,500 shares
- Cme Group Inc~$306.8MAdded · 0.3% → 1.4%+1,833,687 shares
- Jpmorgan Chase & Co~$292.6MAdded · 2.6% → 3.3%+3,039,489 shares
Largest sells
Since Q2 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Amazon~$1.07BCut · 7.3% → 3.1%−340,614 shares
- Comcast Corp New~$854.8MCut · 4.8% → 1.7%−18,478,611 shares
- Uber~$511.9MSold out · 2.2% → 0.0%−16,470,839 shares
- Jd.Com Inc~$497.5MSold out · 2.1% → 0.0%−8,266,459 shares
- Salesforce~$401.9MSold out · 1.7% → 0.0%−2,145,463 shares
- Anaplan Inc~$260.4MSold out · 1.1% → 0.0%−5,746,829 shares
- Cigna Corp New~$254.7MCut · 2.4% → 0.9%−1,503,213 shares
- Lowes Cos Inc~$231.1MSold out · 1.0% → 0.0%−1,710,360 shares
- Sherwin Williams Co~$229.9MSold out · 1.0% → 0.0%−397,835 shares
- Linde Plc~$170.5MSold out · 0.7% → 0.0%−803,694 shares
Holdings
As of Sep 30, 2020. Changes are in shares against Jun 30, 2020, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +123% · price +3.4% | 6.3% | $1.74B | +$25.3M | ||||||||
| Adaptive Biotechnologies CorCOM · shares 0% · price +0.5% | 5.9% | $1.63B | +$8.4M | ||||||||
| Fidelity Natl Information SvCOM · shares +32% · price +9.8% | 4.7% | $1.31B | +$88.1M | ||||||||
| American Express CoCOM · shares +3.3% · price +5.3% | 3.9% | $1.09B | +$53.0M | ||||||||
| Centene Corp DelCOM · shares +8.3% · price −8.2% | 3.7% | $1.02B | −$84.1M | ||||||||
| Bridgebio Pharma IncCOM · shares 0% · price +15.1% | 3.6% | $998.8M | +$130.7M | ||||||||
| T-Mobile Us IncCOM · shares +112% · price +9.8% | 3.3% | $922.9M | +$38.8M | ||||||||
| Jpmorgan Chase & CoCOM · shares +47% · price +2.3% | 3.3% | $909.8M | +$14.2M | ||||||||
| AmazonCOM · shares −56% · price +14.1% | 3.1% | $857.3M | +$106.2M | ||||||||
| Hilton Worldwide Hldgs IncCOM · shares +21% · price +16.2% | 2.7% | $753.5M | +$86.3M | ||||||||
| Boston Scientific CorpCOM · shares +2.0% · price +8.8% | 2.6% | $719.5M | +$57.2M | ||||||||
| Aon PlcSHS CL A · shares +1.9% · price +7.1% | 2.2% | $621.6M | +$40.5M | ||||||||
| Thermo Fisher Scientific IncCOM · shares −21% · price +21.9% | 2.2% | $608.1M | +$109.0M | ||||||||
| Booking Holdings IncCOM · shares +72% · price +7.4% | 2.2% | $596.1M | +$24.0M | ||||||||
| Nuance Communications IncCOM · shares +33% · price +31.2% | 2.0% | $563.7M | +$100.9M | ||||||||
| Fortive CorpCOM · shares −22% · price +12.6% | 1.9% | $519.5M | +$58.3M | ||||||||
| MercadoLibreCOM · shares +583% · price +9.8% | 1.9% | $512.5M | +$6.7M | ||||||||
| Parker-Hannifin CorpCOM · shares +75% · price +10.4% | 1.8% | $509.6M | +$27.5M | ||||||||
| TSMCSPONSORED ADS · shares New | 1.8% | $498.3M | — | ||||||||
| Api Group CorpCOM STK · shares 0% · price +17.1% | 1.7% | $474.3M | +$69.3M | ||||||||
| Comcast Corp NewCL A · shares −65% · price +18.7% | 1.7% | $464.7M | +$73.1M | ||||||||
| Guardant Health IncCOM · shares +26% · price +37.8% | 1.6% | $430.9M | +$94.0M | ||||||||
| Las Vegas Sands CorpCOM · shares −23% · price +2.5% | 1.4% | $400.8M | +$9.6M | ||||||||
| Chubb LimitedCOM · shares +55% · price −8.3% | 1.4% | $396.7M | −$23.1M | ||||||||
| Cme Group IncCOM · shares +380% · price +2.9% | 1.4% | $387.6M | +$2.3M | ||||||||
| Total · 86 positions | 100% | $27.68B | +$1.38B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2020 to Q3 2020: 54 stocks held throughout, up $1.38B (+8.1%).
- Bridgebio Pharma Inc+$130.7M+15%
- Thermo Fisher Scientific Inc+$109.0M+22%
- Amazon+$106.2M+14%
- Nuance Communications Inc+$100.9M+31%
- Guardant Health Inc+$94.0M+38%
- Chubb Limited−$23.1M−8%
- Bristol-Myers Squibb Co−$24.5M−37%
- Cigna Corp New−$26.4M−10%
- Zentalis Pharmaceuticals Inc−$68.1M−32%
- Centene Corp Del−$84.1M−8%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |